Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shuai Dong, Ph.D.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
The Ohio State University, Columbus, OHPhD12/2017Pharmaceutics
2018
Helen Fellow, Dana-Farber Cancer Institute
2017
The Young Investigators Meeting (YIM) Travel Scholarship-XVII International Workshop on CLL
2016
Pelotonia Graduate Fellowship, The Ohio State University Comprehensive Cancer Center
2015
Eli Lily and Co. Graduate Fellowship, The Ohio State University College of Pharmacy
2016
First Place poster in Translational Science, The Ohio State University Comprehensive Cancer Center
2016
First Place poster in Graduate Student Division, The Ohio State University College of Pharmacy
2015
Abstract Achievement Award, 57th American Society of Hematology (ASH) Annual Meeting & Exposition
2015
Best Abstract Award in Clinical and Translational Science, The Ohio State University
2015
Honored lifetime member, National Rho Chi Pharmacy Honor Society
2014
Sponsored Membership, American Association for the Advancement of Science (AAAS)
2008
Predoctoral Fellowship Award, University of Toledo, Toledo, OH

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Paz K, Flynn R, Du J, Tannheimer S, Johnson AJ, Dong S, Stark AK, Okkenhaug K, Panoskaltsis-Mortari A, Sage PT, Sharpe AH, Luznik L, Ritz J, Soiffer RJ, Cutler CS, Koreth J, Antin JH, Miklos DB, MacDonald KP, Hill GR, Maillard I, Serody JS, Murphy WJ, Munn DH, Feser C, Zaiken M, Vanhaesebroeck B, Turka LA, Byrd JC, Blazar BR. Targeting PI3Kd function for amelioration of murine chronic graft-versus-host disease. Am J Transplant. 2019 Jun; 19(6):1820-1830. PMID: 30748099.
    Citations:    
  2. Mitchell SR, Larkin K, Grieselhuber NR, Lai TH, Cannon M, Orwick S, Sharma P, Asemelash Y, Zhang P, Goettl VM, Beaver L, Mims A, Puduvalli VK, Blachly JS, Lehman A, Harrington B, Henderson S, Breitbach JT, Williams KE, Dong S, Baloglu E, Senapedis W, Kirschner K, Sampath D, Lapalombella R, Byrd JC. Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia. Blood Adv. 2019 Feb 12; 3(3):242-255. PMID: 30692102.
    Citations:    
  3. Dong S, Harrington BK, Hu EY, Greene JT, Lehman AM, Tran M, Wasmuth RL, Long M, Muthusamy N, Brown JR, Johnson AJ, Byrd JC. PI3K p110d inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression. J Clin Invest. 2019 Jan 02; 129(1):122-136. PMID: 30457982.
    Citations:    Fields:    
  4. Dong S, Ghobrial IM. Autologous graft versus myeloma: it's not a myth. J Clin Invest. 2019 Jan 02; 129(1):48-50. PMID: 30457981.
    Citations:    Fields:    
  5. Dong S, Byrd JC. A New Role for Lyn in the CLL Microenvironment. Cancer Cell. 2016 10 10; 30(4):511-512. PMID: 27728800.
    Citations:    Fields:    Translation:HumansCells
  6. Liu TM, Woyach JA, Zhong Y, Lozanski A, Lozanski G, Dong S, Strattan E, Lehman A, Zhang X, Jones JA, Flynn J, Andritsos LA, Maddocks K, Jaglowski SM, Blum KA, Byrd JC, Dubovsky JA, Johnson AJ. Hypermorphic mutation of phospholipase C, ?2 acquired in ibrutinib-resistant CLL confers BTK independency upon B-cell receptor activation. Blood. 2015 Jul 02; 126(1):61-8. PMID: 25972157.
    Citations: 31     Fields:    Translation:HumansAnimalsCells
  7. Zhong Y, Dong S, Strattan E, Ren L, Butchar JP, Thornton K, Mishra A, Porcu P, Bradshaw JM, Bisconte A, Owens TD, Verner E, Brameld KA, Funk JO, Hill RJ, Johnson AJ, Dubovsky JA. Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694. J Biol Chem. 2015 Mar 06; 290(10):5960-78. PMID: 25593320.
    Citations: 2     Fields:    Translation:HumansCells
  8. Dong S, Guinn D, Dubovsky JA, Zhong Y, Lehman A, Kutok J, Woyach JA, Byrd JC, Johnson AJ. IPI-145 antagonizes intrinsic and extrinsic survival signals in chronic lymphocytic leukemia cells. Blood. 2014 Dec 04; 124(24):3583-6. PMID: 25258342.
    Citations: 25     Fields:    Translation:HumansCellsCTClinical Trials
  9. Dong S, Zhao Y, Liu H, Yang X, Wang K. Duality of effect of La3+ on mitochondrial permeability transition pore depending on the concentration. Biometals. 2009 Dec; 22(6):917-26. PMID: 19399629.
    Citations:    Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Dong's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (58)
Explore
_
Co-Authors (10)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.